PharmaEssentia USA
@pharmaessentia.bsky.social
Managing a polycythemia vera (PV) diagnosis can be overwhelming, especially when newly diagnosed.
We’ve curated resources to help patients navigate both the physical and emotional aspects of living with PV.
Check it out: piecetogetherpv.com/resources/
We’ve curated resources to help patients navigate both the physical and emotional aspects of living with PV.
Check it out: piecetogetherpv.com/resources/
January 23, 2026 at 1:47 PM
Managing a polycythemia vera (PV) diagnosis can be overwhelming, especially when newly diagnosed.
We’ve curated resources to help patients navigate both the physical and emotional aspects of living with PV.
Check it out: piecetogetherpv.com/resources/
We’ve curated resources to help patients navigate both the physical and emotional aspects of living with PV.
Check it out: piecetogetherpv.com/resources/
We had a great week connecting with investors and the broader biotech community at #JPM2026.
Thank you to everyone who took the time to meet with our team. We appreciated the opportunity to share our recent progress and what’s on the horizon for 2026!
Thank you to everyone who took the time to meet with our team. We appreciated the opportunity to share our recent progress and what’s on the horizon for 2026!
January 16, 2026 at 7:38 PM
We had a great week connecting with investors and the broader biotech community at #JPM2026.
Thank you to everyone who took the time to meet with our team. We appreciated the opportunity to share our recent progress and what’s on the horizon for 2026!
Thank you to everyone who took the time to meet with our team. We appreciated the opportunity to share our recent progress and what’s on the horizon for 2026!
Today we’re excited to announce that the US FDA has accepted our sBLA for ropeginterferon alfa-2b-njft for the treatment of patients with essential thrombocythemia (ET), with a PDUFA target action date of August 30, 2026.
Press Release: us.pharmaessentia.com/fda-confirms...
Press Release: us.pharmaessentia.com/fda-confirms...
January 13, 2026 at 5:36 PM
Today we’re excited to announce that the US FDA has accepted our sBLA for ropeginterferon alfa-2b-njft for the treatment of patients with essential thrombocythemia (ET), with a PDUFA target action date of August 30, 2026.
Press Release: us.pharmaessentia.com/fda-confirms...
Press Release: us.pharmaessentia.com/fda-confirms...
This morning we’re excited to share that our Phase 2b EXCEED-ET clinical study met its primary objectives, demonstrating significant efficacy with a consistent treatment response across the overall ET population.
us.pharmaessentia.com/pharmaessent...
us.pharmaessentia.com/pharmaessent...
January 12, 2026 at 1:22 PM
This morning we’re excited to share that our Phase 2b EXCEED-ET clinical study met its primary objectives, demonstrating significant efficacy with a consistent treatment response across the overall ET population.
us.pharmaessentia.com/pharmaessent...
us.pharmaessentia.com/pharmaessent...
Median survival for #PV is ~9.1–12.6 years, but new research and therapeutic approaches are reshaping this outlook.
At PharmaEssentia, we remain committed to advancing PV care through science and insight.
At PharmaEssentia, we remain committed to advancing PV care through science and insight.
January 9, 2026 at 9:03 PM
Median survival for #PV is ~9.1–12.6 years, but new research and therapeutic approaches are reshaping this outlook.
At PharmaEssentia, we remain committed to advancing PV care through science and insight.
At PharmaEssentia, we remain committed to advancing PV care through science and insight.
Happy New Year!
A new year brings new possibilities. As we enter 2026, we’re proud to reflect on the progress of the past year and are excited by the opportunities ahead of us.
A new year brings new possibilities. As we enter 2026, we’re proud to reflect on the progress of the past year and are excited by the opportunities ahead of us.
January 6, 2026 at 2:33 PM
Happy New Year!
A new year brings new possibilities. As we enter 2026, we’re proud to reflect on the progress of the past year and are excited by the opportunities ahead of us.
A new year brings new possibilities. As we enter 2026, we’re proud to reflect on the progress of the past year and are excited by the opportunities ahead of us.
2025 brought us closer to our goal of serving patients with MPNs — from hosting PV in Focus events to launching a new patient-focused website and strengthening advocacy partnerships worldwide.
Thank you to the patients, caregivers, physicians, and advocates who continue to inspire us!
Thank you to the patients, caregivers, physicians, and advocates who continue to inspire us!
December 31, 2025 at 1:28 PM
2025 brought us closer to our goal of serving patients with MPNs — from hosting PV in Focus events to launching a new patient-focused website and strengthening advocacy partnerships worldwide.
Thank you to the patients, caregivers, physicians, and advocates who continue to inspire us!
Thank you to the patients, caregivers, physicians, and advocates who continue to inspire us!
2025 was a year of tremendous progress!
We reached a major clinical milestone with our Phase 3 SURPASS-ET trial, partnered to expand into Brazil and Argentina, grew to 700+ employees, and shared new science across global stages. Here’s to more innovation and impact in 2026!
We reached a major clinical milestone with our Phase 3 SURPASS-ET trial, partnered to expand into Brazil and Argentina, grew to 700+ employees, and shared new science across global stages. Here’s to more innovation and impact in 2026!
December 30, 2025 at 3:13 PM
2025 was a year of tremendous progress!
We reached a major clinical milestone with our Phase 3 SURPASS-ET trial, partnered to expand into Brazil and Argentina, grew to 700+ employees, and shared new science across global stages. Here’s to more innovation and impact in 2026!
We reached a major clinical milestone with our Phase 3 SURPASS-ET trial, partnered to expand into Brazil and Argentina, grew to 700+ employees, and shared new science across global stages. Here’s to more innovation and impact in 2026!
We’re excited to unveil a new look for our corporate website!
Our new site captures our evolving story, from pioneering treatments for MPNs to showcasing our in-house manufacturing capabilities, R&D innovations, and beyond.
Check it out: us.pharmaessentia.com
Our new site captures our evolving story, from pioneering treatments for MPNs to showcasing our in-house manufacturing capabilities, R&D innovations, and beyond.
Check it out: us.pharmaessentia.com
December 28, 2025 at 1:05 PM
We’re excited to unveil a new look for our corporate website!
Our new site captures our evolving story, from pioneering treatments for MPNs to showcasing our in-house manufacturing capabilities, R&D innovations, and beyond.
Check it out: us.pharmaessentia.com
Our new site captures our evolving story, from pioneering treatments for MPNs to showcasing our in-house manufacturing capabilities, R&D innovations, and beyond.
Check it out: us.pharmaessentia.com
We’re excited to welcome Jeffrey R. Williams to our Board of Directors!
With decades of experience in global finance and governance, Jeffrey will help guide our next chapter of global growth.
Read more: www.businesswire.com/news/home/20...
With decades of experience in global finance and governance, Jeffrey will help guide our next chapter of global growth.
Read more: www.businesswire.com/news/home/20...
December 24, 2025 at 2:14 PM
We’re excited to welcome Jeffrey R. Williams to our Board of Directors!
With decades of experience in global finance and governance, Jeffrey will help guide our next chapter of global growth.
Read more: www.businesswire.com/news/home/20...
With decades of experience in global finance and governance, Jeffrey will help guide our next chapter of global growth.
Read more: www.businesswire.com/news/home/20...
As 2025 draws to a close we pause to reflect on an incredible year of progress and collaboration and look toward the future with optimism.
From all of us at PharmaEssentia, we wish you happy holidays and a prosperous new year!
From all of us at PharmaEssentia, we wish you happy holidays and a prosperous new year!
December 23, 2025 at 3:16 PM
As 2025 draws to a close we pause to reflect on an incredible year of progress and collaboration and look toward the future with optimism.
From all of us at PharmaEssentia, we wish you happy holidays and a prosperous new year!
From all of us at PharmaEssentia, we wish you happy holidays and a prosperous new year!
Every breakthrough begins with a bold vision.
Ours began in the 90s with our founder, Dr. Ko-Chung Lin, and his pioneering research into interferons and PEGylation. Today we are a global, fully integrated company transforming MPN care.
Learn more: us.pharmaessentia.com/about/#history
Ours began in the 90s with our founder, Dr. Ko-Chung Lin, and his pioneering research into interferons and PEGylation. Today we are a global, fully integrated company transforming MPN care.
Learn more: us.pharmaessentia.com/about/#history
December 16, 2025 at 6:19 PM
Every breakthrough begins with a bold vision.
Ours began in the 90s with our founder, Dr. Ko-Chung Lin, and his pioneering research into interferons and PEGylation. Today we are a global, fully integrated company transforming MPN care.
Learn more: us.pharmaessentia.com/about/#history
Ours began in the 90s with our founder, Dr. Ko-Chung Lin, and his pioneering research into interferons and PEGylation. Today we are a global, fully integrated company transforming MPN care.
Learn more: us.pharmaessentia.com/about/#history
We’re heading to San Francisco for #JPM2026!
Our leadership team is excited to share updates on our growth, pipeline progress, and the ways we’re continuing to advance and transform care for people living with myeloproliferative neoplasms.
www.businesswire.com/news/home/20...
Our leadership team is excited to share updates on our growth, pipeline progress, and the ways we’re continuing to advance and transform care for people living with myeloproliferative neoplasms.
www.businesswire.com/news/home/20...
December 15, 2025 at 3:03 PM
We’re heading to San Francisco for #JPM2026!
Our leadership team is excited to share updates on our growth, pipeline progress, and the ways we’re continuing to advance and transform care for people living with myeloproliferative neoplasms.
www.businesswire.com/news/home/20...
Our leadership team is excited to share updates on our growth, pipeline progress, and the ways we’re continuing to advance and transform care for people living with myeloproliferative neoplasms.
www.businesswire.com/news/home/20...
Another ASH conference is in the books!
We were energized by the conversations, new discoveries, and opportunities to connect with those who share our passion for advancing care for patients with hematologic diseases. We’re excited to carry this momentum forward into 2026!
We were energized by the conversations, new discoveries, and opportunities to connect with those who share our passion for advancing care for patients with hematologic diseases. We’re excited to carry this momentum forward into 2026!
December 12, 2025 at 1:12 PM
Another ASH conference is in the books!
We were energized by the conversations, new discoveries, and opportunities to connect with those who share our passion for advancing care for patients with hematologic diseases. We’re excited to carry this momentum forward into 2026!
We were energized by the conversations, new discoveries, and opportunities to connect with those who share our passion for advancing care for patients with hematologic diseases. We’re excited to carry this momentum forward into 2026!
We’re excited to be at #ASH25. We laced up for today’s ASH Foundation Run/Walk and have enjoyed learning about the latest innovations in hematology.
Attending? Stop by our booth (#1501) and check out our posters to learn more about our research and developments in MPN.
Attending? Stop by our booth (#1501) and check out our posters to learn more about our research and developments in MPN.
December 8, 2025 at 2:40 AM
We’re excited to be at #ASH25. We laced up for today’s ASH Foundation Run/Walk and have enjoyed learning about the latest innovations in hematology.
Attending? Stop by our booth (#1501) and check out our posters to learn more about our research and developments in MPN.
Attending? Stop by our booth (#1501) and check out our posters to learn more about our research and developments in MPN.
It’s been an incredible start to #ASH25! Attending? Stop by our booth (#1501) and check out our posters to learn more about how we’re advancing MPN care.
December 7, 2025 at 3:21 AM
It’s been an incredible start to #ASH25! Attending? Stop by our booth (#1501) and check out our posters to learn more about how we’re advancing MPN care.
As the year starts to wind down, our team recently gathered for our quarterly team meeting—a chance to pause, connect, and reflect on our achievements before heading into the holiday season. Moments like these remind us that shared purpose drives everything we do.
November 25, 2025 at 7:15 PM
As the year starts to wind down, our team recently gathered for our quarterly team meeting—a chance to pause, connect, and reflect on our achievements before heading into the holiday season. Moments like these remind us that shared purpose drives everything we do.
This past weekend we wrapped up the final PV in Focus event of 2025 in Houston!
Thank you to everyone who joined us throughout the year to make these events such a meaningful space for PV education and connection.
Be on the lookout for more events to come in 2026!
Thank you to everyone who joined us throughout the year to make these events such a meaningful space for PV education and connection.
Be on the lookout for more events to come in 2026!
November 20, 2025 at 5:43 PM
This past weekend we wrapped up the final PV in Focus event of 2025 in Houston!
Thank you to everyone who joined us throughout the year to make these events such a meaningful space for PV education and connection.
Be on the lookout for more events to come in 2026!
Thank you to everyone who joined us throughout the year to make these events such a meaningful space for PV education and connection.
Be on the lookout for more events to come in 2026!
PharmaEssentia is excited to share new data at #ASH25, December 6-9 in Orlando!
We’re proud to advance the science of MPNs and look forward to connecting with the hematology community.
Read more: us.pharmaessentia.com/wp-content/u...
We’re proud to advance the science of MPNs and look forward to connecting with the hematology community.
Read more: us.pharmaessentia.com/wp-content/u...
November 18, 2025 at 1:10 PM
PharmaEssentia is excited to share new data at #ASH25, December 6-9 in Orlando!
We’re proud to advance the science of MPNs and look forward to connecting with the hematology community.
Read more: us.pharmaessentia.com/wp-content/u...
We’re proud to advance the science of MPNs and look forward to connecting with the hematology community.
Read more: us.pharmaessentia.com/wp-content/u...
Living with a rare disease impacts more than the body — it affects mental health, too.
In this PV Pod episode, psychologist Dr. Al Freedman shares insights on PV mental health challenges, blending expertise with his experiences as a rare disease parent.
podcasts.apple.com/us/podcast/m...
In this PV Pod episode, psychologist Dr. Al Freedman shares insights on PV mental health challenges, blending expertise with his experiences as a rare disease parent.
podcasts.apple.com/us/podcast/m...
November 13, 2025 at 1:32 PM
Living with a rare disease impacts more than the body — it affects mental health, too.
In this PV Pod episode, psychologist Dr. Al Freedman shares insights on PV mental health challenges, blending expertise with his experiences as a rare disease parent.
podcasts.apple.com/us/podcast/m...
In this PV Pod episode, psychologist Dr. Al Freedman shares insights on PV mental health challenges, blending expertise with his experiences as a rare disease parent.
podcasts.apple.com/us/podcast/m...
At PharmaEssentia, we believe a strong culture fuels strong science. We build that culture by bringing our team together for moments that inspire learning, spark connection, and celebrate achievements.
Ready to join in? Explore our open roles: pharmaessentiausa.applytojob.com/apply
Ready to join in? Explore our open roles: pharmaessentiausa.applytojob.com/apply
November 12, 2025 at 1:22 PM
At PharmaEssentia, we believe a strong culture fuels strong science. We build that culture by bringing our team together for moments that inspire learning, spark connection, and celebrate achievements.
Ready to join in? Explore our open roles: pharmaessentiausa.applytojob.com/apply
Ready to join in? Explore our open roles: pharmaessentiausa.applytojob.com/apply
November kicked off with two key gatherings for the MPN community — the CR&T International MPN Patient Symposium and the International Congress on MPNs.
We were honored to connect with patients, advocates, and researchers in conversations that reinforce our mission.
We were honored to connect with patients, advocates, and researchers in conversations that reinforce our mission.
November 11, 2025 at 2:43 PM
November kicked off with two key gatherings for the MPN community — the CR&T International MPN Patient Symposium and the International Congress on MPNs.
We were honored to connect with patients, advocates, and researchers in conversations that reinforce our mission.
We were honored to connect with patients, advocates, and researchers in conversations that reinforce our mission.
We’re excited to welcome Dr. Barry Flannelly to our Board of Directors!
With 25+ years in biopharma and deep expertise in MPNs, Dr. Flannelly’s leadership will help drive our next phase of growth and innovation.
Read more: us.pharmaessentia.com/wp-content/u...
With 25+ years in biopharma and deep expertise in MPNs, Dr. Flannelly’s leadership will help drive our next phase of growth and innovation.
Read more: us.pharmaessentia.com/wp-content/u...
November 10, 2025 at 3:39 PM
We’re excited to welcome Dr. Barry Flannelly to our Board of Directors!
With 25+ years in biopharma and deep expertise in MPNs, Dr. Flannelly’s leadership will help drive our next phase of growth and innovation.
Read more: us.pharmaessentia.com/wp-content/u...
With 25+ years in biopharma and deep expertise in MPNs, Dr. Flannelly’s leadership will help drive our next phase of growth and innovation.
Read more: us.pharmaessentia.com/wp-content/u...
Don’t miss the final PV in Focus event of 2025!
Join us in Houston on November 15 for a day dedicated to the polycythemia vera community, with education, resources, and connection for patients, friends, and families.
More info and registration: pvinfocus.com
Join us in Houston on November 15 for a day dedicated to the polycythemia vera community, with education, resources, and connection for patients, friends, and families.
More info and registration: pvinfocus.com
November 4, 2025 at 3:20 PM
Don’t miss the final PV in Focus event of 2025!
Join us in Houston on November 15 for a day dedicated to the polycythemia vera community, with education, resources, and connection for patients, friends, and families.
More info and registration: pvinfocus.com
Join us in Houston on November 15 for a day dedicated to the polycythemia vera community, with education, resources, and connection for patients, friends, and families.
More info and registration: pvinfocus.com
Self-advocacy is vital for any rare disease, and polycythemia vera (PV) is no exception.
In this episode of PV Pod: Stories from the Marrow, Susan shares how staying informed and connected within PV communities helped her play an active role in her care.
podcasts.apple.com/us/podcast/s...
In this episode of PV Pod: Stories from the Marrow, Susan shares how staying informed and connected within PV communities helped her play an active role in her care.
podcasts.apple.com/us/podcast/s...
October 30, 2025 at 3:16 PM
Self-advocacy is vital for any rare disease, and polycythemia vera (PV) is no exception.
In this episode of PV Pod: Stories from the Marrow, Susan shares how staying informed and connected within PV communities helped her play an active role in her care.
podcasts.apple.com/us/podcast/s...
In this episode of PV Pod: Stories from the Marrow, Susan shares how staying informed and connected within PV communities helped her play an active role in her care.
podcasts.apple.com/us/podcast/s...